Fundraising Fox

M132026 Investments

4 investments dated 2026 · listed companies and verified rows first · show all

Roger Labsrogerhealthcare.cominJul 2026SEC filingmedium confidence

Roger is an AI documentation platform for home health agencies that completes OASIS assessments and routine visit notes, with near real-time EHR syncing.

AI & Machine LearningDigital HealthHealthtechBerkeley, US

Yunus Ansari(Executive Officer, Director)inYusef Iskandar(Executive Officer, Director)inKeyur K Shah(Founder)

BoardKeysur Shah(Director)

Board seatKarl Alomar· per SEC Form D · $24.5M raise · filed Jul 2026

Avantosavantos.aiinFeb 2026 · $25M

Avantos is an AI-native operating system for client management that uses AI agents to handle onboarding, servicing, and growth workflows while integrating with existing enterprise technology stacks.

AI & Machine LearningEnterprise SoftwareFintech

Rabih Ramadi(Founder)inBassam Chaptini(Founder)in

Co-investorsBessemer Venture PartnersBlue CollectiveThe E14 Fund

Chordchord.coin𝕏Apr 2026 · $7M

Chord provides a unified data layer and AI agents for commerce brands, combining reliable data infrastructure with autonomous tools that operate across the full business stack.

AI & Machine LearningData & InfrastructureE-commerceMarketing Tech

Bryan Mahoney(CEO & Co-Founder)Henry Davis(President & Chairman)

Co-investorsAlleyCorpBright Pixel CapitalEqual VenturesIntercept VenturesRidge VenturesAlley Robotics Ventures+2 more

Rimerime.aiin𝕏Jun 2026

Rime builds voice AI models designed for real-time human conversation, offering 600+ customizable voices with adjustable accent, pace, and tone.

AI & Machine LearningDeep TechSaaSSan Francisco, US

Lily Clifford(Executive Officer, Director)inBrooke Larson(Founder)

BoardAres Geovanos(Director)John Vrionis(Director)inMorgan Blumberg(Director)inSandhya Hedge(Director)

Co-investorsCorazon CapitalMoth FundUnusual VenturesM13 VenturesSEEDRA VenturesTwilio Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.